Form 4: Indaptus Therapeutics CFO Nir Sassi Disposes of Stock Options
SEC Form 4
Nir Sassi, CFO of Indaptus Therapeutics, disposed of several stock option holdings on April 10, 2025, through a mutual agreement with the company.
Summary
- On April 10, 2025, Nir Sassi, the Chief Financial Officer of Indaptus Therapeutics, Inc., disposed of multiple stock option holdings.
- The transactions involved the cancellation of stock options with various exercise prices, including $25.72, $34.32, $72, $357.28, $331.2, and $610.24.
- The total consideration received by Sassi for the cancellation of these options was $500.
- Following these transactions, Sassi's direct ownership of these specific derivative securities is now zero.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock option disposals. It doesn't inherently indicate positive or negative sentiment about the company's future prospects.
Industry Context
Executive compensation and stock option grants are common in the biotechnology industry to incentivize performance and align management interests with shareholders. Changes in these holdings can be indicative of management's view of the company's prospects, although in this case it was a mutual agreement.
Comparison to Industry Standards
- Stock option grants are a standard component of compensation packages for executives in publicly traded companies, particularly in the biotech sector.
- The specific terms of option grants (exercise price, vesting schedule, expiration date) vary widely based on company size, stage of development, and individual performance.
- Comparing the exercise prices and grant dates of these options to those of executives at similar-stage biotech companies (e.g., early-stage drug development firms) could provide context on the competitiveness of Indaptus Therapeutics' compensation practices.
- The cancellation of options by mutual agreement is less common but can occur in various circumstances, such as renegotiation of employment terms or strategic changes within the company.
Key Dates
| Date | Description |
|---|---|
| 07/25/2016 | Date of stock options that were disposed of. |
| 03/27/2016 | Date of stock options that were disposed of. |
| 01/22/2019 | Date of stock options that were disposed of. |
| 09/13/2019 | Date of stock options that were disposed of. |
| 02/17/2020 | Date of stock options that were disposed of. |
| 09/16/2020 | Date of stock options that were disposed of. |
| 04/10/2025 | Date of transaction: Nir Sassi disposed of stock options. |
| 04/11/2025 | Date of signature on the Form 4. |
Keywords
Form 4, Indaptus Therapeutics, Nir Sassi, stock options, disposal, CFO, INDP
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.